TFF Pharmaceuticals (TFFP) Competitors $1.97 -0.53 (-21.20%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TFFP vs. RDHL, MEIP, BTAI, ALGS, NAII, ICCC, BIVI, BGXX, INKT, and IBIOShould you be buying TFF Pharmaceuticals stock or one of its competitors? The main competitors of TFF Pharmaceuticals include RedHill Biopharma (RDHL), MEI Pharma (MEIP), BioXcel Therapeutics (BTAI), Aligos Therapeutics (ALGS), Natural Alternatives International (NAII), ImmuCell (ICCC), BioVie (BIVI), Bright Green (BGXX), MiNK Therapeutics (INKT), and iBio (IBIO). These companies are all part of the "pharmaceutical products" industry. TFF Pharmaceuticals vs. RedHill Biopharma MEI Pharma BioXcel Therapeutics Aligos Therapeutics Natural Alternatives International ImmuCell BioVie Bright Green MiNK Therapeutics iBio RedHill Biopharma (NASDAQ:RDHL) and TFF Pharmaceuticals (NASDAQ:TFFP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking. Do insiders and institutionals hold more shares of RDHL or TFFP? 7.2% of RedHill Biopharma shares are owned by institutional investors. Comparatively, 15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 6.8% of RedHill Biopharma shares are owned by company insiders. Comparatively, 4.5% of TFF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, RDHL or TFFP? RedHill Biopharma has higher revenue and earnings than TFF Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRedHill Biopharma$6.53M1.59$23.92MN/AN/ATFF Pharmaceuticals$730K9.36-$21.24M-$7.88-0.25 Does the media favor RDHL or TFFP? In the previous week, RedHill Biopharma had 2 more articles in the media than TFF Pharmaceuticals. MarketBeat recorded 2 mentions for RedHill Biopharma and 0 mentions for TFF Pharmaceuticals. RedHill Biopharma's average media sentiment score of 0.42 beat TFF Pharmaceuticals' score of 0.00 indicating that RedHill Biopharma is being referred to more favorably in the media. Company Overall Sentiment RedHill Biopharma Neutral TFF Pharmaceuticals Neutral Which has more risk and volatility, RDHL or TFFP? RedHill Biopharma has a beta of 3.68, indicating that its stock price is 268% more volatile than the S&P 500. Comparatively, TFF Pharmaceuticals has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Does the MarketBeat Community favor RDHL or TFFP? RedHill Biopharma received 360 more outperform votes than TFF Pharmaceuticals when rated by MarketBeat users. However, 67.68% of users gave TFF Pharmaceuticals an outperform vote while only 67.56% of users gave RedHill Biopharma an outperform vote. CompanyUnderperformOutperformRedHill BiopharmaOutperform Votes42767.56% Underperform Votes20532.44% TFF PharmaceuticalsOutperform Votes6767.68% Underperform Votes3232.32% Is RDHL or TFFP more profitable? RedHill Biopharma has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -1,612.73%. RedHill Biopharma's return on equity of 0.00% beat TFF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets RedHill BiopharmaN/A N/A N/A TFF Pharmaceuticals -1,612.73%-225.15%-170.07% Do analysts rate RDHL or TFFP? TFF Pharmaceuticals has a consensus target price of $44.00, indicating a potential upside of 2,133.50%. Given TFF Pharmaceuticals' higher probable upside, analysts plainly believe TFF Pharmaceuticals is more favorable than RedHill Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RedHill Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ATFF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryRedHill Biopharma beats TFF Pharmaceuticals on 10 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TFFP vs. The Competition Export to ExcelMetricTFF PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.84M$7.02B$5.32B$8.52BDividend YieldN/A7.92%5.07%4.13%P/E Ratio-0.2512.25127.5316.08Price / Sales9.36396.061,490.6892.20Price / CashN/A47.4339.5134.18Price / Book0.495.604.765.07Net Income-$21.24M$153.56M$118.77M$225.46M7 Day Performance-16.88%-1.46%-0.38%0.06%1 Month Performance8.84%15.32%6.06%3.93%1 Year Performance-72.06%43.07%38.14%32.50% TFF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TFFPTFF Pharmaceuticals1.9966 of 5 stars$1.97-21.2%$44.00+2,133.5%-72.1%$8.67M$730,000.00-0.2519RDHLRedHill Biopharma1.0369 of 5 stars$8.01-2.4%N/A-96.9%$10.17M$6.53M0.00210MEIPMEI Pharma4.7286 of 5 stars$3.17+2.6%$7.00+120.8%-56.3%$21.11M$65.30M1.19100Analyst ForecastNews CoverageGap DownHigh Trading VolumeBTAIBioXcel Therapeutics4.1811 of 5 stars$0.71+6.0%$5.00+603.4%-85.4%$28.96M$2.40M-0.2090Short Interest ↑News CoverageALGSAligos Therapeutics4.6842 of 5 stars$9.36+5.5%$75.00+701.3%-49.1%$28.35M$7.97M-0.4690Upcoming EarningsHigh Trading VolumeNAIINatural Alternatives International1.0223 of 5 stars$4.55+0.4%N/A-24.4%$28.21M$113.80M-3.70290Analyst ForecastICCCImmuCell0.6704 of 5 stars$3.59+0.6%N/A-29.9%$28.05M$23.22M-6.7775Positive NewsBIVIBioVie2.5741 of 5 stars$2.56-10.8%$4.00+56.3%-39.8%$26.79MN/A-0.1910Gap DownHigh Trading VolumeBGXXBright GreenN/A$0.14flatN/A-63.5%$26.15MN/A-2.292Gap DownINKTMiNK Therapeutics1.9469 of 5 stars$0.75flat$9.00+1,101.9%-30.5%$26.00MN/A-1.5330News CoverageGap UpIBIOiBio1.0468 of 5 stars$2.81-2.1%$4.30+53.0%N/A$25.68M$225,000.000.00100 Related Companies and Tools Related Companies RedHill Biopharma Competitors MEI Pharma Competitors BioXcel Therapeutics Competitors Aligos Therapeutics Competitors Natural Alternatives International Competitors ImmuCell Competitors BioVie Competitors Bright Green Competitors MiNK Therapeutics Competitors iBio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TFFP) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TFF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
